Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

NCT06329570 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme
Glioblastoma
Glioma
Brain Tumor
Neoplasms
Neoplasms, Nerve Tissue

Interventions

DEVICE: NaviFUS System
DRUG: Lumason
DRUG: Bevacizumab

Sponsor

NaviFUS Corporation

Collaborators

[object Object]